1.
Bioorg Med Chem Lett
; 13(4): 697-700, 2003 Feb 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12639561
RESUMO
A novel series of benzamidines was synthesized and shown to exhibit NR2B-subtype selective NMDA antagonist activity. Compound 31 is orally active in a carrageenan-induced rat hyperalgesia model of pain and shows no motor coordination side effects.